THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 156 filers reported holding THERAPEUTICSMD INC in Q3 2019. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,000 | -20.0% | 11,508 | -12.8% | 0.00% | – |
| Q4 2021 | $5,000 | -81.5% | 13,191 | -64.0% | 0.00% | -100.0% |
| Q3 2021 | $27,000 | -38.6% | 36,642 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $44,000 | 0.0% | 36,596 | +10.5% | 0.00% | -50.0% |
| Q1 2021 | $44,000 | +51.7% | 33,108 | +37.2% | 0.00% | +100.0% |
| Q4 2020 | $29,000 | -12.1% | 24,130 | +15.5% | 0.00% | -50.0% |
| Q3 2020 | $33,000 | +26.9% | 20,883 | +2.3% | 0.00% | +100.0% |
| Q2 2020 | $26,000 | +30.0% | 20,421 | +8.3% | 0.00% | -50.0% |
| Q1 2020 | $20,000 | -61.5% | 18,859 | -12.1% | 0.00% | 0.0% |
| Q4 2019 | $52,000 | -11.9% | 21,448 | +31.9% | 0.00% | -33.3% |
| Q3 2019 | $59,000 | +20.4% | 16,260 | -14.0% | 0.00% | +50.0% |
| Q2 2019 | $49,000 | -56.6% | 18,904 | -18.6% | 0.00% | -60.0% |
| Q1 2019 | $113,000 | -35.4% | 23,237 | -49.5% | 0.01% | -54.5% |
| Q4 2018 | $175,000 | -50.3% | 46,050 | -14.2% | 0.01% | -15.4% |
| Q3 2018 | $352,000 | – | 53,679 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,660,108 | $60,749,000 | 7.08% |
| VHCP Management, LLC | 846,500 | $4,410,000 | 2.37% |
| Broadfin Capital, LLC | 2,128,159 | $11,088,000 | 1.46% |
| OUTFITTER ADVISORS, LTD. | 333,484 | $1,737,000 | 0.69% |
| GILDER GAGNON HOWE & CO LLC | 7,547,644 | $39,323,000 | 0.56% |
| Granite Point Capital Management, L.P. | 240,000 | $1,250,000 | 0.21% |
| EAM Investors, LLC | 221,885 | $1,156,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 135,208 | $704,000 | 0.14% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 70,000 | $365,000 | 0.06% |
| GAM Holding AG | 427,450 | $2,227,000 | 0.04% |